Cases & Deals

Celgene defends its leading product Revlimid® against patent revocation actions in UK

Clients Celgene Corporation

Jones Day acted for Celgene Corporation in multiple cases brought by Accord Healthcare in the UK High Court (patents court) in relation to Celgene's patents concerning its best-selling drug, Revlimid®.

Accord Healthcare Limited v. Celgene Corporation, HP 2017 000036, 000038 (UK High Court)